Brain Neuroplasticity after Treatment with Antiseizure: A Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Epilepsy is a disease characterized by the periodic occurrence of seizures. Seizures can be controlled by antiseizure medications, which can improve the lives of individuals with epilepsy when given proper treatment. Therefore, this study aimed to review the scientific literature on brain neuroplasticity after treatment with antiseizure drugs in different regions of the brain. According to the findings, that several antiseizure, such as lamotrigine, diazepam, levetiracetam, and valproic acid, in addition to controlling seizures, can also act on neuroplasticity in different brain regions. The study of this topic becomes important, as it will help to understand the neuroplastic mechanisms of these drugs, in addition to helping to improve the effectiveness of these drugs in controlling the disease.
Abstract
Epilepsy is a disease characterized by the periodic occurrence of seizures. Seizures can be controlled by antiseizure medications, which can improve the lives of individuals with epilepsy when given proper treatment. Therefore, this study aimed to review the scientific literature on brain neuroplasticity after treatment with antiseizure drugs in different regions of the brain. According to the findings, that several antiseizure, such as lamotrigine, diazepam, levetiracetam, and valproic acid, in addition to controlling seizures, can also act on neuroplasticity in different brain regions. The study of this topic becomes important, as it will help to understand the neuroplastic mechanisms of these drugs, in addition to helping to improve the effectiveness of these drugs in controlling the disease.
참고문헌 (52)
- Al-Otaibi F, "An overview of structurally diversified anticonvulsant agents", Acta Pharm, 69, pp.321~344 (2019)
- Duygu Aksoy, "Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy", Clinical Psychopharmacology and Neuroscience, 14(1), pp.74~78 (2016), 대한정신약물학회
- Beghi E, "The epidemiology of epilepsy", Neuroepidemiology, 54, pp.185~191 (2020)
- Akyuz E, "Revisiting the role of neurotransmitters in epilepsy : An updated review", Life Sci, 265, pp.118826~ (2021)
- Dahlin M, "The gut microbiome and epilepsy", EBioMedicine, 44, pp.741~746 (2019)
- Kania BF, "Introduction to neural plasticity mechanism", J Behav Brain Sci, 7, pp.41~49 (2017)
- Cramer SC, "Harnessing neuroplasticity for clinical applications", Brain, 134, pp.1591~1609 (2011)
- Sasmita AO, "Harnessing neuroplasticity : Modern approaches and clinical future", Int J Neurosci, 128, pp.1061~1077 (2018)
- Beyhan N, "Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcone", Arab J Chem, 10(Suppl 2), pp.S2073~S2081 (2017)
- Thijs RD, "Epilepsy in adults", Lancet, 393, pp.689~701 (2019)
- LaPenna P, "The pharmacology and toxicology of third-generation anticonvulsant drugs", J Med Toxicol, 13, pp.329~342 (2017)
- Hiroyuki Mizoguchi, "Roles of Matrix Metalloproteinases and Their Targets in Epileptogenesis and Seizures", Clinical Psychopharmacology and Neuroscience, 11(2), pp.45~52 (2013), 대한정신약물학회
- Manford M, "Recent advances in epilepsy", J Neurol, 264, pp.1811~1824 (2017)
- Anwar H, "Epileptic seizures", Discoveries(Craiova), 8, pp.e110~ (2020)
- Boison D, "The biochemistry and epigenetics of epilepsy : Focus on adenosine and glycine", Front Mol Neurosci, 9, pp.26~ (2016)
- Koch E, "Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning", Pharmacoepidemiol Drug Saf, 32, pp.446~454 (2023)
- Brodie MJ, "Combining antiepileptic drugs--rational polytherapy?", Seizure, 20, pp.369~375 (2011)
- Hawkins NA, "Screening of conventional anticonvulsants in a genetic mouse model of epilepsy", Ann Clin Transl Neurol, 4, pp.326~339 (2017)
- Dalkara S, "Recent progress in anticonvulsant drug research : Strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders", Curr Top Med Chem, 12, pp.1033~1071 (2012)
- Palma E, "Modulation of GABAA receptors in the treatment of epilepsy", Curr Pharm Des, 23, pp.5563~5568 (2017)
- Stefan H, "Novel anticonvulsant drugs", Pharmacol Ther, 113, pp.165~183 (2007)
- Löscher W, "The ups and downs of alkyl-carbamates in epilepsy therapy : How does cenobamate differ?", Epilepsia, 62, pp.596~614 (2021)
- Zhu MM, "The pharmacogenomics of valproic acid", J Hum Genet, 62, pp.1009~1014 (2017)
- Lamb S, "Neuroplasticity : A century-old idea championed by Adolf Meyer", CMAJ, 191, pp.E1359~E1361 (2019)
- Demarin V, "Neuroplasticity", Period Biol, 116, pp.209~211 (2014)
- Wenger E, "The learning hippocampus : Education and experience-dependent plasticity", Mind, Brain, and Education, 10, pp.171~183 (2016)
- Garcés-Vieira MV, "Neuroplasticity : biochemical and neurophysiological aspects", CES Med, 28, pp.119~132 (2014)
- Feldman DE, "Synaptic mechanisms for plasticity in neocortex", Annu Rev Neurosci, 32, pp.33~55 (2009)
- Wu H, "Occupational neuroplasticity in the human brain : A critical review and meta-analysis of neuroimaging studies", Front Hum Neurosci, 14, pp.215~ (2020)
- Shaffer J, "Neuroplasticity and clinical practice : Building brain power for health", Front Psychol, 7, pp.1118~ (2016)
- Liu B, "From serotonin to neuroplasticity : Evolvement of theories for major depressive disorder", Front Cell Neurosci, 11, pp.305~ (2017)
- Gulyaeva NV, "Molecular mechanisms of neuroplasticity: An expanding universe", Biochemistry(Mosc), 82, pp.237~242 (2017)
- Toricelli M, "Mechanisms of neuroplasticity and brain degeneration : Strategies for protection during the aging process", Neural Regen Res, 16, pp.58~67 (2021)
- Cichon N, "Flavonoids as a natural enhancer of neuroplasticity-an overview of the mechanism of neurorestorative action", Antioxidants(Basel), 9, pp.1035~ (2020)
- de Oliveira RMW, "Neuroplasticity", J Chem Neuroanat, 108, pp.101822~ (2020)
- El-shaer NH, "Patho-immunohistochemical study on the neuro-protective effects of ginkobiloba against carbamazepine-induced neurotoxicity in experimental albino rats", J Chem Pharm Res, 10, pp.174~181 (2018)
- Delvendahl I, "Effects of lamotrigine on human motor cortex plasticity", Clin Neurophysiol, 124, pp.148~153 (2013)
- Huopaniemi L, "Diazepam-induced adaptive plasticity revealed by alpha1GABAA receptor-specific expression profiling", J Neurochem, 88, pp.1059~1067 (2004)
- Christensen KV, "Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats", BMC Neurosci, 11, pp.9~ (2010)
- Ghiglieri V, "TrkB", BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy : Modulation by valproic acid, 2010, pp.35, 1531~1540
- Jessberger S, "Epigenetic modulation of seizure-induced neurogenesis and cognitive decline", J Neurosci, 27, pp.5967~5975 (2007)
- Zhang X, "PI3K", AKT, Stem Cell Reports, pp.2017, 8[DOI]
- Kinjo T, "Prenatal exposure to valproic acid is associated with altered neurocognitive function and neurogenesis in the dentate gyrus of male offspring rats", Brain Res, 1723, pp.146403~ (2019)
- Pannangrong W, "Valproic acid withdrawal ameliorates impairments of hippocampal-spatial working memory and neurogenesis", J Zhejiang Univ Sci B, 20, pp.253~263 (2019)
- Fujimura K, "In utero exposure to valproic acid induces neocortical dysgenesis via dysregulation of neural progenitor cell proliferation", differentiation, 2016, pp.36, 10908~10919
- Ideta-Otsuka M, "Epigenetic toxicity of environmental chemicals upon exposure during development-bisphenol A and valproic acid may have epigenetic effects", Food Chem Toxicol, 109, pp.812~816 (2017)
- Sakai A, "Ectopic neurogenesis induced by prenatal antiepileptic drug exposure augments seizure susceptibility in adult mice", Proc Natl Acad Sci U S A, 115, pp.4270~4275 (2018)
- Gao J, "Epigenetic regulation of GABAergic differentiation in the developing brain", Front Cell Neurosci, 16, pp.988732~ (2022)
- Sgobio C, "Hippocampal synaptic plasticity, memory, and epilepsy : Effects of long-term valproic acid treatment", Biol Psychiatry, 67, pp.567~574 (2010)
- Umka J, "Valproic acid reduces spatial working memory and cell proliferation in the hippocampus", Neuroscience, 166, pp.15~22 (2010)
- Salaka RJ, "Differential effects of levetiracetam on hippocampal CA1 synaptic plasticity and molecular changes in the dentate gyrus in epileptic rats", Neurochem Int, 158, pp.105378~ (2022)
- González-H G, "Levetiracetam reduced the basal excitability of the dentate gyrus without restoring impaired synaptic plasticity in rats with temporal lobe epilepsy", Brain Sci, 10, pp.634~ (2020)
